TRANSNASAL SPHENOPALATINE GANGLION BLOCK, AN INNOVATIVE MODALITY FOR TREATMENT OF POST DURAL PUNCTURAL HEADACHE
Objective: To evaluate the efficacy of a new& novel technique Sphenopalatine Ganglion Block (SPG) for the treatment of post duralpunctural headache (PDPH) at Combined Military Hospital, Skardu.
Study Design: Case series.
Place and Duration of Study: The study was conducted at department of Anesthesiology, pain and intensive care, Combined Military Hospital, Skardu, from Mar to Oct 2017.
Material and Methods: Total of 53 patients of PDPH fulfilling inclusion criteria were offered SPG block and their response was quantified on visual analogue scale (VAS) from 0-10.
Results: Out of total n=53 all the patients were females, the age of the patients were between 18-37 years, with themean of 27.08 and ± SD of 5.188), VAS score before undergoing SPG block was between 8 and 10 with the mean of 9.377 ± SD 0.664. For the patients after undergoing SPG block significant decrease on mean i.e. 1.175 with ±SD 0.657 was noted with p-value<0.001 which was considered significant.
Conclusion: SPG block was found more innovative modality for treating post duralpunctural headache.